Currently out of the existing stock ratings of Gobind Singh, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Gobind Singh

Work Performance Price Targets & Ratings Chart

Analyst Gobind Singh, has had 55.56% of price targets met with an average potential upside of 42.45%, reached in 271 days on average. Previously, Gobind Singh worked at HC WAINWRIGHT, JMP.

Gobind Singh has documented 36 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on RPHM, at 08-Sep-2023.

Wall Street Analyst Gobind Singh

Analyst best performing recommendations are on RPHM.
The best stock recommendation documented was for RPHM on 9/19/2022. The price target of $31 was fulfilled within 8 days with a profit of $9.8 (24.02%), with a performance score of 30.02.

Average potential price target upside

EVLO Evelo Biosciences IMUX Immunic KLDO PTGX Protagonist Therapeutics PRTA Prothena plc RPHM

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$80

3 years 3 months 26 days ago
(26-Jul-2023)

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

$10

$10

3 years 8 months 4 days ago
(17-Mar-2023)

2/2 (100%)

$4.82 (93.05%)

79

Buy

$5

3 years 8 months 5 days ago
(16-Mar-2023)

1/1 (100%)

$-0.98 (-16.39%)

4

Buy

$280

3 years 9 months 20 days ago
(01-Feb-2023)

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

$50

$12

4 years 5 days ago
(16-Nov-2022)

3/4 (75%)

$4.2 (9.17%)

100

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?